4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Revelation Biosciences, Inc. (REVB) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 8 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, REVB reported $0M in revenue and ($9M) in net income.
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($9M) | ($8M) | ($9M) | ($11M) |
| Net Income | ($9M) | ($15M) | ($0M) | ($11M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($3M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($3M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $12M | $7M | $12M | $6M | — |
| Total Liabilities | $3M | $2M | $6M | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive REVB viewer.
About TickerBase · Data methodology & sources